Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation.

BACKGROUND In a randomized trial comparing mitral-valve repair with mitral-valve replacement in patients with severe ischemic mitral regurgitation, we found no significant difference in the left ventricular end-systolic volume index (LVESVI), survival, or adverse events at 1 year after surgery. However, patients in the repair group had significantly more recurrences of moderate or severe mitral regurgitation. We now report the 2-year outcomes of this trial. METHODS We randomly assigned 251 patients to mitral-valve repair or replacement. Patients were followed for 2 years, and clinical and echocardiographic outcomes were assessed. RESULTS Among surviving patients, the mean (±SD) 2-year LVESVI was 52.6±27.7 ml per square meter of body-surface area with mitral-valve repair and 60.6±39.0 ml per square meter with mitral-valve replacement (mean changes from baseline, -9.0 ml per square meter and -6.5 ml per square meter, respectively). Two-year mortality was 19.0% in the repair group and 23.2% in the replacement group (hazard ratio in the repair group, 0.79; 95% confidence interval, 0.46 to 1.35; P=0.39). The rank-based assessment of LVESVI at 2 years (incorporating deaths) showed no significant between-group difference (z score=-1.32, P=0.19). The rate of recurrence of moderate or severe mitral regurgitation over 2 years was higher in the repair group than in the replacement group (58.8% vs. 3.8%, P<0.001). There were no significant between-group differences in rates of serious adverse events and overall readmissions, but patients in the repair group had more serious adverse events related to heart failure (P=0.05) and cardiovascular readmissions (P=0.01). On the Minnesota Living with Heart Failure questionnaire, there was a trend toward greater improvement in the replacement group (P=0.07). CONCLUSIONS In patients undergoing mitral-valve repair or replacement for severe ischemic mitral regurgitation, we observed no significant between-group difference in left ventricular reverse remodeling or survival at 2 years. Mitral regurgitation recurred more frequently in the repair group, resulting in more heart-failure-related adverse events and cardiovascular admissions. (Funded by the National Institutes of Health and Canadian Institutes of Health Research; ClinicalTrials.gov number, NCT00807040.).

[1]  Y. Okita,et al.  Mitral valve replacement versus annuloplasty for treating severe functional mitral regurgitation , 2013, General Thoracic and Cardiovascular Surgery.

[2]  G. Lamas,et al.  Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators. , 1997, Circulation.

[3]  Gideon Cohen,et al.  Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. , 2004, The Journal of thoracic and cardiovascular surgery.

[4]  Jong-Min Song,et al.  Mitral Valve Repair Versus Revascularization Alone in the Treatment of Ischemic Mitral Regurgitation , 2006, Circulation.

[5]  B. Lytle,et al.  Is repair preferable to replacement for ischemic mitral regurgitation? , 2001, The Journal of thoracic and cardiovascular surgery.

[6]  E. Schwammenthal,et al.  Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. , 2005, Circulation.

[7]  James D. Thomas,et al.  Echocardiographic predictors of successful versus unsuccessful mitral valve repair in ischemic mitral regurgitation. , 2006, The American journal of cardiology.

[8]  T. Trikalinos,et al.  Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach. , 2010, Journal of the American College of Cardiology.

[9]  Jiayang Wang,et al.  Mitral valve replacement therapy causes higher 30-day postoperative mortality than mitral valvuloplasty in patients with severe ischemic mitral regurgitation: A meta-analysis of 12 studies. , 2015, International journal of cardiology.

[10]  H. Rayatzadeh,et al.  A prospective study of predicting factors in ischemic mitral regurgitation recurrence after ring annuloplasty. , 2007, The Annals of thoracic surgery.

[11]  Philippe Pibarot,et al.  Ischemic Mitral Regurgitation: A Complex Multifaceted Disease , 2008, Cardiology.

[12]  Jeroen J. Bax,et al.  Predictors of mitral regurgitation recurrence in patients with heart failure undergoing mitral valve annuloplasty. , 2010, The American journal of cardiology.

[13]  R. Levine,et al.  Mechanism of Recurrent Ischemic Mitral Regurgitation After Annuloplasty: Continued LV Remodeling as a Moving Target , 2004, Circulation.

[14]  M. Acker,et al.  Optimal surgical management of severe ischemic mitral regurgitation: to repair or to replace? , 2012, Journal of Thoracic and Cardiovascular Surgery.

[15]  Timothy J Gardner,et al.  Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. , 2014, The New England journal of medicine.

[16]  P. Pibarot,et al.  Continued global left ventricular remodeling is not the sole mechanism responsible for the late recurrence of ischemic mitral regurgitation after restrictive annuloplasty. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[17]  O. Alfieri,et al.  Recurrence of mitral regurgitation parallels the absence of left ventricular reverse remodeling after mitral repair in advanced dilated cardiomyopathy. , 2008, The Annals of thoracic surgery.

[18]  Denis Bouchard,et al.  Predicting recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation. , 2015, The Journal of thoracic and cardiovascular surgery.

[19]  S. Markwell,et al.  Meta-analysis of short-term and long-term survival following repair versus replacement for ischemic mitral regurgitation. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[20]  R. Levine,et al.  Mechanism of Persistent Ischemic Mitral Regurgitation After Annuloplasty: Importance of Augmented Posterior Mitral Leaflet Tethering , 2005, Circulation.

[21]  G. Filippatos,et al.  [Guidelines on the management of valvular heart disease]. , 2013, Revista espanola de cardiologia.

[22]  G. Gensini,et al.  Five-year echocardiographic results of combined undersized mitral ring annuloplasty and coronary artery bypass grafting for chronic ischaemic mitral regurgitation. , 2007, European heart journal.

[23]  F. Harrell,et al.  Current prognosis of ischemic mitral regurgitation. Implications for future management. , 1988, Circulation.

[24]  M. Acker,et al.  Mitral valve surgery in advanced heart failure. , 2010, Journal of the American College of Cardiology.

[25]  R. Levine,et al.  Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. , 2003, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[26]  Wojciech Zareba,et al.  Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.

[27]  M. Caputo,et al.  Determinants of functional capacity after mitral valve annuloplasty or replacement for ischemic mitral regurgitation. , 2015, The Journal of thoracic and cardiovascular surgery.

[28]  P. Pibarot,et al.  Preoperative Posterior Leaflet Angle Accurately Predicts Outcome After Restrictive Mitral Valve Annuloplasty for Ischemic Mitral Regurgitation , 2007, Circulation.

[29]  S. Gallina,et al.  Recurrence of functional mitral regurgitation in patients with dilated cardiomyopathy undergoing mitral valve repair: how to predict it. , 2007, Interactive cardiovascular and thoracic surgery.

[30]  R. Levine,et al.  Mechanism of Recurrent/Persistent Ischemic/Functional Mitral Regurgitation in the Chronic Phase After Surgical Annuloplasty: Importance of Augmented Posterior Leaflet Tethering , 2006, Circulation.

[31]  J B Seward,et al.  Determinants of the Degree of Functional Mitral Regurgitation in Patients With Systolic Left Ventricular Dysfunction: A Quantitative Clinical Study , 2000, Circulation.

[32]  Jeroen J. Bax,et al.  Restrictive Annuloplasty and Coronary Revascularization in Ischemic Mitral Regurgitation Results in Reverse Left Ventricular Remodeling , 2004, Circulation.

[33]  P. Pibarot,et al.  Mitral Repair versus Replacement for Ischemic Mitral Regurgitation: Comparison of Short-Term and Long-Term Survival , 2009, Circulation.

[34]  C. Tribble,et al.  Mitral Repair Is Superior to Replacement When Associated With Coronary Artery Disease , 2004, Annals of surgery.

[35]  D. C. Miller,et al.  Randomized trial comparing partial versus complete chordal-sparing mitral valve replacement: effects on left ventricular volume and function. , 2002, The Journal of thoracic and cardiovascular surgery.

[36]  M. Enriquez-Sarano,et al.  Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy , 2011, Heart.

[37]  J. Cohn,et al.  Ventricular remodeling in heart failure: a credible surrogate endpoint. , 2003, Journal of cardiac failure.

[38]  O. Alfieri,et al.  Guidelines on the management of valvular heart disease (version 2012). , 2012, European heart journal.

[39]  P. Austin,et al.  Mitral repair versus replacement for ischemic mitral regurgitation. , 2005, The Annals of thoracic surgery.

[40]  T. Rector,et al.  Use of the Living With Heart Failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death. , 1995, Journal of cardiac failure.

[41]  R. Levine,et al.  Comprehensive Annular and Subvalvular Repair of Chronic Ischemic Mitral Regurgitation Improves Long-Term Results With the Least Ventricular Remodeling , 2012, Circulation.

[42]  R M Whitlock,et al.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. , 1987, Circulation.